Contact Us

Magnetic iron oxide nanoparticles as drug carriers

Significant preclinical and clinical research has explored the use of magnetic iron oxide nanoparticles (MNPs) for medical theranostics. Herein, we provide an overview of the optimal 'design-to-perform' MNPs used in cancer therapeutics, specifically focusing on magnetic hyperthermia, magnetic drug targeting, and targeting delivery.

Magnetic iron oxide nanoparticles as drug carriers

Magnetic nanoparticles (MNPs), particularly made of iron oxides, have been extensively studied as diagnostic imaging agents and therapeutic delivery vehicles. In this review, special emphasis is set on the 'recent advancements of drug-conjugated MNPs used for

Magnetic iron oxide nanoparticles as drug carriers

2018-1-29  Magnetic iron oxide nanoparticles as drug carriers: clinical relevance. Kheireddine El-Boubbou Department of Basic Sciences, College of Science & Health Professions, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, National Guard Health Affairs, Riyadh 11481, Saudi Arabia.

Magnetic iron oxide nanoparticles as drug carriers

Request PDF Magnetic iron oxide nanoparticles as drug carriers: Clinical relevance Significant preclinical and clinical research has explored the use of magnetic iron oxide nanoparticles (MNPs

Magnetic iron oxide nanoparticles as drug carriers

Significant preclinical and clinical research has explored the use of magnetic iron oxide nanoparticles (MNPs) for medical theranostics. Herein, we provide an overview of the optimal 'design-to-perform' MNPs used in cancer therapeutics, specifically focusing on magnetic hyperthermia, magnetic drug targeting, and targeting delivery. An account of the progress

Magnetic iron oxide nanoparticles as drug carriers

Significant preclinical and clinical research has explored the use of magnetic iron oxide nanoparticles (MNPs) for medical theranostics. Herein, we provide an overview of the optimal 'design-to-perform'

Magnetic iron oxide nanoparticles for drug delivery

Introduction: For many years, the controlled delivery of therapeutic compounds has been a matter of great interest in the field of nanomedicine. Among the wide amount of drug nanocarriers, magnetic iron oxide nanoparticles (IONs) stand out from the crowd and constitute robust nanoplatforms since they can achieve high drug loading as well as targeting abilities stemming

Magnetic Nanomedicine SpringerLink

2019-11-8  El-Boubbou K. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance. Nanomedicine. 2018;13:953–71. PubMed PubMedCentral CrossRef Google Scholar

Magnetic iron oxide nanoparticles as drug carriers: clinical

2018-12-11  Significant preclinical and clinical research has explored the use of magnetic iron oxide nanoparticles (MNPs) for medical theranostics. Herein, we provide an overview of the optimal 'design-to-perform' MNPs used in cancer therapeutics, specifically focusing on magnetic hyperthermia, magnetic drug targeting, and targeting delivery.

Magnetic iron oxide nanoparticles as drug carriers

Significant preclinical and clinical research has explored the use of magnetic iron oxide nanoparticles (MNPs) for medical theranostics. Herein, we provide an overview of the optimal 'design-to-perform'

Magnetic Nanoparticles as Drug Carriers Request PDF

Request PDF On Sep 1, 2006, Urso O. Häfeli and others published Magnetic Nanoparticles as Drug Carriers Find, read and cite all the research you need on ResearchGate

(PDF) Biomedical Applications of Iron Oxide Nanoparticles

2022-1-16  Summarizing the fundamental properties of the magnetic iron oxide nanoparticles, the review’s next Many of these studies ignore the long

Iron Oxide Mesoporous Magnetic Nanostructures with

2021-4-14  Many synthetic routes have been suggested to produce nano-scaled mesostructures of iron oxides. In fact, the majority of research has focused on preparation of iron oxide magnetic nanoparticles (IO-MNPs) coated with mesoporous silica

Magnetic Nanomedicine SpringerLink

2019-11-8  El-Boubbou K. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance. Nanomedicine. 2018;13:953–71. PubMed PubMedCentral CrossRef Google Scholar

Iron Oxide Nanoparticles for Biomedical Applications: A

2018-6-9  Medical applications and biotechnological advances, including magnetic resonance imaging, cell separation and detection, tissue repair, magnetic hyperthermia and drug delivery, have strongly benefited from employing iron oxide nanoparticles (IONPs) due to their remarkable properties, such as superparamagnetism, size and possibility of receiving a biocompatible

Targeting cancer cells: magnetic nanoparticles as drug

2006-1-31  Magnetic drug targeting employing nanoparticles as carriers is a promising cancer treatment avoiding side effects of conventional chemotherapy. We used iron oxide nanoparticles covered by starch derivatives with phosphate groups which bound mitoxantrone as chemotherapeutikum. In this letter we show that a strong magnetic field gradient at the tumour

Iron Oxide Nanoparticles for Biomedical Applications

2018-1-1  2.1.Iron Nanoparticles: Advantages and Limitations for Biomedical Applications 2.1.1.Context. In the field of the synthesis and functionalization of inorganic nanoparticles (NPs) for biomedical applications, most researches aim at developing multifunctional theranostic NPs that can both identify disease states and deliver therapy and allow thus following the effect of

Biochemical functionality of magnetic particles as

2019-5-31  Magnetic nanosensors have become attractive instruments for the diagnosis and treatment of different diseases. They represent an efficient carrier system in drug delivery or in transporting contrast agents. For such purposes, magnetic nanosensors are used in vivo (intracorporeal application). To remove specific compounds from blood, magnetic nanosensors

Magnetic iron oxide nanoparticles as drug carriers

Mentioning: 56 Significant preclinical and clinical research has explored the use of magnetic iron oxide nanoparticles (MNPs) for medical theranostics. Herein, we provide an overview of the optimal 'design-to-perform' MNPs used in cancer therapeutics, specifically focusing on magnetic hyperthermia, magnetic drug targeting, and targeting delivery.

Magnetic iron oxide nanoparticles as drug carriers

2018-3-16  Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery. Kheireddine El-Boubbou Department of Basic Sciences, College of Science & Health Professions, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, National Guard Health Affairs, Riyadh 11481, Saudi Arabia.

Magnetic iron oxide nanoparticles as drug delivery system

2013-9-15  Magnetic iron oxide nanoparticles as drug delivery system in breast cancer. Violamycine B1 (VB1) has a high binding efficiency to DNA but its clinical use is not allowed due to severe side-effects, such as cardiotoxicity . VB1 is the only antracyclinic antibiotic with two amino-sugar groups which are supposed to play a role in the coating

Magnetic Nanoparticles as Drug Carriers Request PDF

Request PDF On Sep 1, 2006, Urso O. Häfeli and others published Magnetic Nanoparticles as Drug Carriers Find, read and cite all the research you need on ResearchGate

Targeting cancer cells: magnetic nanoparticles as drug

It is shown that a strong magnetic field gradient at the tumour location accumulates the nanoparticles and electron microscope investigations show that the ferrofluids can be enriched in tumour tissue and tumour cells. Magnetic drug targeting employing nanoparticles as carriers is a promising cancer treatment avoiding side effects of conventional chemotherapy. We used iron

(PDF) Biomedical Applications of Iron Oxide Nanoparticles

2022-1-16  Summarizing the fundamental properties of the magnetic iron oxide nanoparticles, the review’s next Many of these studies ignore the long

Cancer therapy with iron oxide nanoparticles: Agents of

2020-1-1  For cancer therapies, clinical experience is the measure of success and serves to validate scientific paradigms used in preclinical product development. To date, approved cancer nanomedicines are liposomal drug delivery, and magnetic iron oxide nanoparticle-based magnetic fluid hyperthermia.

Targeted magnetic iron oxide nanoparticles for tumor

Magnetic iron oxide (IO) nanoparticles with a long blood retention time, biodegradability and low toxicity have emerged as one of the primary nanomaterials for biomedical applications in vitro and in vivo.IO nanoparticles have a large surface area and can be engineered to provide a large number of functional groups for cross-linking to tumor-targeting ligands such as monoclonal

Preparation of iron oxide mesoporous magnetic

2019-7-1  El-Boubbou, K. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance. Nanomedicine 13,953–971 (2018). CAS PubMed Article PubMed Central Google Scholar

Biochemical functionality of magnetic particles as

2019-5-31  Magnetic nanosensors have become attractive instruments for the diagnosis and treatment of different diseases. They represent an efficient carrier system in drug delivery or in transporting contrast agents. For such purposes, magnetic nanosensors are used in vivo (intracorporeal application). To remove specific compounds from blood, magnetic nanosensors